triumph trial retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the registrational clinical trials Retatrutide Phase 3: TRIUMPH Program

36 A post-hoc analysis of the FIGHT trial also demonstrated a trend towards an increase in arrhythmic events in patients on liraglutide (21 versus 39

Most reported patients who have developed an AKI had risk factors contributing to volume depletion, or comorbidities that increased their risk, or took other nephrotoxic medications in combination with GLP-1 RAs [18]

The cellular mechanism (hypothesis-stage but increasingly cited) The more important finding for at-home treatment selection is that GLP-1 receptor agonists may age the face through pathways beyond fat loss alone

It starts with an initial dose of 0.25 mg, increased every 4 weeks until the maximum maintenance dose of 2.4 mg is reached

You need to do whats called a randomized trial, where you give half of people a drug like semaglutide and half of the people not, then you follow them to see if there are lower rates of depression